Literature DB >> 25341577

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.

Nicholas Simon Reed1, Patricia Pautier, Elizabeth Åvall-Lundqvist, Chel-Hun Choi, Andreas du Bois, Michael Friedlander, Anthony Fyles, Ganessan Kichenadasse, Diane M Provencher, Isabelle Ray-Coquard.   

Abstract

Small cell carcinomas of the ovary are uncommon and account for less than 1% of ovarian cancers. They were first recognized in 1979, and a number of reports appeared during the next 2 decades. They are highly aggressive tumors and usually carry a poor prognosis, although this may reflect that most are diagnosed at advanced stage; however, those diagnosed as stage 1A have only 30% to 40% of long-term survivors. More reports followed extending our experience in the diagnosis and management of these rare cancers. The classification is described below and shown in Table 1, but a revision is expected to be published from the World Health Organization in 2014.

Entities:  

Mesh:

Year:  2014        PMID: 25341577     DOI: 10.1097/IGC.0000000000000293

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

1.  Rare ovarian tumours. Other treatments for ovarian cancer.

Authors:  Marta Gil-Martin; Beatriz Pardo; Maria-Pilar Barretina-Ginesta
Journal:  EJC Suppl       Date:  2020-08-22

2.  Prevalence, Associated Factors, and Survival Outcomes of Small-Cell Neuroendocrine Carcinoma of the Gynecologic Tract: A Large Population-Based Analysis.

Authors:  Li Pang; Shizhuo Wang
Journal:  Front Med (Lausanne)       Date:  2022-04-11

Review 3.  Primary ovarian small cell carcinoma of pulmonary type with coexisting endometrial carcinoma in a breast cancer patient receiving tamoxifen: A case report and literature review.

Authors:  Lei Yin; Jianning Li; Yunhai Wei; Dejian Ma; Yamei Sun; Yanlai Sun
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

4.  Primary neuroendocrine tumors of the ovary: Management and outcomes.

Authors:  Li Pang; Zhiqiang Guo
Journal:  Cancer Med       Date:  2021-11-12       Impact factor: 4.452

5.  Retrospective Analysis of Clinicopathological Features and Prognosis of Gynecological Small-Cell Carcinoma.

Authors:  Li Pang; Hui Yang; Yuer Ning; Chunyu Zheng
Journal:  Cancer Manag Res       Date:  2021-06-08       Impact factor: 3.989

Review 6.  Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines.

Authors:  Marc Tischkowitz; Sidong Huang; Susana Banerjee; Jennifer Hague; William P D Hendricks; David G Huntsman; Jessica D Lang; Krystal A Orlando; Amit M Oza; Patricia Pautier; Isabelle Ray-Coquard; Jeffrey M Trent; Michael Witcher; Leora Witkowski; W Glenn McCluggage; Douglas A Levine; William D Foulkes; Bernard E Weissman
Journal:  Clin Cancer Res       Date:  2020-03-10       Impact factor: 13.801

7.  Primary small cell ovarian cancer of pulmonary type: A case report.

Authors:  Emmanouil Kalampokas; Vijay Sharma; Tanja Gagliardi; Fiona Payne; Mahalakshmi Gurumurthy
Journal:  Gynecol Oncol Rep       Date:  2018-02-08

8.  Small cell carcinoma of the ovary, pulmonary type: A role for adjuvant radiotherapy after carboplatin and etoposide?

Authors:  Anase S Asom; Ricardo R Lastra; Yasmin Hasan; Lori Weinberg; Gini F Fleming; Katherine C Kurnit
Journal:  Gynecol Oncol Rep       Date:  2022-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.